Physician profile
Paul W Bauer
NPI 1942265285
$4,444.96
in general payments reported to CMS, 2019-2025
9 companies · $2,575 in 2025
The $2,575 reported for 2025 was more than what 93% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,239 · 2020: $55.78 · 2021: $61.86 · 2022: $248 · 2023: $240 · 2024: $24.62 · 2025: $2,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,111 · Food and Beverage: $624 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,111.00 |
| Food and Beverage | $624.35 |
| Travel and Lodging | $104.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $3,473.23 | 2019-2025 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit |
| Cochlear Americas | $456.45 | 2019-2023 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Acclarent, INC | $211.10 | 2019-2023 | Relieva Spinplus |
| Alk-Abello, INC | $99.74 | 2021-2025 | Neffy, Timothy, Standardized, Standardized Mite D. Farinae |
| Arbor Pharmaceuticals, INC. | $97.67 | 2019-2020 | |
| Smith+Nephew, INC. | $47.79 | 2020-2023 | Tula |
| Novartis Pharmaceuticals Corporation | $25.58 | 2019 | |
| Medtronic, INC. | $19.53 | 2023 | Propel |
| Integra Lifesciences Corporation | $13.87 | 2023 | Integra, Instruments-Orthopedic, Microfrance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.